Form 4: BioCardia Director Stertzer Acquires Additional Shares
SEC Form 4 Filing
Director Simon H. Stertzer purchased 1,000 shares of BioCardia, Inc. common stock at $2.45 per share on March 5, 2025.
Summary
- On March 5, 2025, Simon H. Stertzer, a director of BioCardia, Inc., acquired 1,000 shares of common stock at a price of $2.45 per share.
- Following this transaction, Stertzer directly owns 57,138 shares and indirectly owns 59,204 shares through the Stertzer Family Trust, 15,379 shares through Windrock Enterprises L.L.C., 777 shares through the Stertzer Gamma Trust, and 6,102 shares through Stertzer Holdings LLC.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase suggests confidence, but it's a small transaction relative to overall holdings.
Positives
- The director's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into a company's prospects, although they are not definitive indicators of future performance.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Simon H. Stertzer purchased 1,000 shares of BioCardia, Inc. common stock. |
| 03/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.